Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
2.960
-0.040 (-1.33%)
At close: Nov 20, 2024, 4:00 PM
2.900
-0.060 (-2.03%)
Pre-market: Nov 21, 2024, 5:48 AM EST
Galmed Pharmaceuticals Market Cap
Galmed Pharmaceuticals has a market cap or net worth of $4.46 million as of November 21, 2024. Its market cap has increased by 537.24% in one year.
Market Cap
4.46M
Enterprise Value
-12.68M
1-Year Change
537.24%
Ranking
Category
Stock Price
$2.96
Market Cap Chart
Since March 13, 2014, Galmed Pharmaceuticals's market cap has decreased from $145.70M to $4.46M, a decrease of -96.94%. That is a compound annual growth rate of -27.81%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 20, 2024 | 4.50M | 150.00% |
Dec 29, 2023 | 1.80M | -85.71% |
Dec 30, 2022 | 12.60M | -72.43% |
Dec 31, 2021 | 45.70M | -30.44% |
Dec 31, 2020 | 65.70M | -45.93% |
Dec 31, 2019 | 121.50M | 23.23% |
Dec 31, 2018 | 98.60M | -11.33% |
Dec 29, 2017 | 111.20M | 185.13% |
Dec 30, 2016 | 39.00M | -53.85% |
Dec 31, 2015 | 84.50M | 42.98% |
Dec 31, 2014 | 59.10M | -59.44% |
Mar 13, 2014 | 145.70M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sharps Technology | 4.90M |
Purple Biotech | 4.79M |
Aptevo Therapeutics | 4.63M |
Genprex | 4.62M |
Sunshine Biopharma | 4.56M |
Check-Cap | 4.45M |
Cyclerion Therapeutics | 4.43M |
Creative Medical Technology Holdings | 4.41M |